| 123Jump Rating: |
|
Underwriters: |
Morgan Stanley
|
| |
|
|
Deutsche Bank Sec.
|
| Status: |
Filed |
|
|
| |
| Address: |
One Riverfront Place,
|
FiledDate: |
11/09/2007 |
| |
Newport,
|
|
|
| |
KY 41042
|
Filed Price Range ($): |
|
| |
|
|
|
| Telephone: |
859- 371-7581 |
Filed Offer Amount ($ Million): |
$86.00 |
| |
|
|
|
| Fax: |
|
Shares Offered (Millions): |
|
| |
|
|
|
| Websites: |
www.xanodyne.com |
Shares Outstanding (Millions): |
|
| |
|
|
|
| Management: |
Gregory Flexter, CEO
|
IPO Date: |
|
| |
|
|
|
| |
|
Final Offer Price ($): |
$0.00 |
| |
|
|
|
| Industry: |
Pharmaceuticals |
Final Offer Size (Millions of Shares): |
0.00 |
| |
|
|
|
| Employees: |
177 |
Final Offer Amount ($ Million): |
$0.00 |
| |
|
|
|
| Competitors: |
Shire Pharmaceuticals Group
|
S-1 Forms: |
|
| |
ndo Pharmaceuticals Holdings Inc.
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
- Avoid 
- Value Gap 
- Short-Term Growth
- Long-Term Growth 
- Long-Term Value 
